Journal of Vasculitis

Editor-in-Chief

David R W Jayne, Director of the Vasculitis and Lupus Clinic and Reader in Vasculitis University of Cambridge, United Kingdom

About the Journal

The inflammation of blood vessels is called as vasculitis. Vasculitis results in narrowing/close of the blood vessel preventing the blood flow. Vasculitis may occur due to several reasons like allergy, drug induce, environmental changes, hepatitis, blood cancer, rheumatoid arthritis and lupus.

Journal of Vasculitis focuses vasculitis, leukocytoclastic vasculitis, urticarial vasculitis, vasculitis symptoms, ANCA vasculitis, inflammatory vasculitis, autoimmune vasculitis, hypersensitivity vasculitis, vasculitis treatment, cutaneous vasculitis, cerebral vasculitis, necrotizing vasculitis, rheumatoid vasculitis, cryoglobulinemic vasculitis, systemic vasculitis, retinal vasculitis, small vessel vasculitis, cerebral vasculitis, lymphocytic vasculitis, central nervous system vasculitis, ANCA associated vasculitis, pulmonary vasculitis, allergic vasculitis, golfers vasculitis, nodular vasculitis.

Journal of Vasculitis accepts all types of articles including research, review, case reports, commentaries, hypotheses, meeting reports, editorials and short reports. Journal of Vasculitis is using Editorial Tracking System for quality in review process. It is an online manuscript submission, review and tracking system used by most of the best open access journals. Review processing is performed by the editorial board members of Journal or outside experts; at least two independent reviewers approval followed by editor's approval is required for acceptance of any citable manuscript.

 Submit manuscript at https://www.scholarscentral.org/submissions/vasculitis.html as an e-mail attachment to vasculitis@medicalresjournals.com

Rapid Publication Service

Hilaris Publishing is offering wide range of opportunities, options and services for the prospective authors to publish their scholarly contributions.

The journal caters to the demands of the fast publication without compromising on the editorial quality including manuscript peer-review. This flexibility is being provided to ensure earliest author credibility to their respective contributions and this will also ensure timely dissemination of research outcomes for efficient integration, effective translation and reduced redundancy.

Authors have the option to choose between the standard open access publication service which takes its own course of time for complete publication process or can opt for rapid publication service wherein the article is published at the earliest date (Includes multiple subject experts commissioning for securing earliest peer-review comments). The authors can avail this flexibility based on the personal preference, funding agency guidelines or Institutional or organizational requirements.

Regardless of the option, all manuscripts undergo thorough peer-review process, editorial assessment and production process.

Fast Editorial Execution and Review Process (FEE-Review Process)

Authors who are willing to publish their articles under this mode can make a pre-payment of $99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).

Manuscripts accepted for publication will be charged regular APC.

Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.

Recent Articles

• 

  Long-term Outcomes and Quality of Life in Patients with Giant Cell Arteritis: A Longitudinal Study

  Samuel Rodriguez*

  Short Communication

• 

  The Impact of Early Intervention on Renal Function in Patients with Systemic Vasculitis

  Berchi Mancilla*

  Perspective

• 

  Evaluating the Efficacy of Biologic Agents in the Treatment of ANCA-associated Vasculitis

  Atefeh Faramarzi*

  Short Communication

• 

  Evaluating the Efficacy of Biologic Agents in the Treatment of ANCA-associated Vasculitis

  Atefeh Faramarzi*

  Short Communication

• 

  Long-term Outcomes and Quality of Life in Patients with Giant Cell Arteritis: A Longitudinal Study

  Samuel Rodriguez*

  Short Communication

• 

  A Review of Lymphocytic Vasculitis: Mechanisms, Symptoms and Current Treatment Options

  Santos Briz*

  Opinion